Journal
BMJ Open
Publication Date
3-21-2025
Volume
15
Issue
3
First Page
e093663
Document Type
Open Access Publication
DOI
10.1136/bmjopen-2024-093663
Rights and Permissions
DeJong C, Durstenfeld MS, Davis JD, Wang CS, Riley ED, Huffman MD, Hickey MD, Shade SB, Chen JC, Kazi DS, Grochowski J, Steward WT, Zier LS, Moreau N, Sandhu AT, Heidenreich PA, Agarwal A, Hsue PY. Delivering guideline-directed medical therapy for heart failure with reduced ejection fraction as an over-encapsulated polypill: rationale and protocol for the COMBO-HF-X pilot crossover randomised clinical trial. BMJ Open. 2025 Mar 21;15(3):e093663. doi: 10.1136/bmjopen-2024-093663.© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Recommended Citation
DeJong, Colette; Huffman, Mark D; Agarwal, Anubha; and et al., "Delivering guideline-directed medical therapy for heart failure with reduced ejection fraction as an over-encapsulated polypill: Rationale and protocol for the COMBO-HF-X pilot crossover randomised clinical trial." BMJ Open. 15, 3. e093663 (2025).
https://digitalcommons.wustl.edu/oa_4/5364
Department
ICTS (Institute of Clinical and Translational Sciences)
